Condition: ST Elevation Myocardial Infarction · Sponsor: The First Affiliated Hospital with Nanjing Medical University
As an effective treatment for acute ST-segment elevation myocardial infarction (STEMI), early reperfusion may reduce the infarct size and improve the prognosis of patients. However, it remains uncertain whether adjunctive thrombolytic therapy administered immediately prior to primary percutaneous coronary intervention (PCI) improves outcomes in patients undergoing the procedure within 120 minutes. In this investigator-initiated, prospective, multi-center, randomized, double-blind, placebo-controlled trial, subjects meeting the inclusion/exclusion criteria should be randomly assigned 1:1 to the trial group (r-SAK) or the control group (placebo). The risk of major adverse cardiovascular events within 90 days will be observed.
This description comes directly from the study's public registry record.
Chunjian Li, PHD · +86 13701465229 · lijay@njmu.edu.cn
Chen Li, MD · +86 13913886986 · lcicewind@outlook.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
| Changzhou Second People's Hospital | Changzhou, China | Recruiting |
| Changzhou Wujin People's Hospital | Changzhou, China | Recruiting |
| The First People's Hospital of Changzhou | Changzhou, China | Recruiting |
| Chongqing Hospital of Jiangsu Province Hospital | Chongqing, China | Recruiting |
| The second Affiliated Hospital of Dalian Medical University | Dalian, China | Recruiting |
| Daqing Oilfield General Hospital | Daqing, China | Recruiting |
| Dongguan People's Hospital | Dongguan, China | Recruiting |
| Fengcheng People's Hospital | Fengcheng, China | Recruiting |
| General Hospital of Southern Theatre Command | Guangzhou, China | Recruiting |
| The Second Affiliated Hospital of Hainan Medical University | Hainan, China | Recruiting |
| The Affiliated Hospital of Hangzhou Normal University | Hangzhou, China | Recruiting |
+ 49 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05410925